UVA Cancer Center shifts CAR-T therapy to outpatient setting

Charlottesville, Va.-based UVA Cancer Center is offering some patients chimeric antigen receptor T-cell therapy in an outpatient setting.

Advertisement

Previously, CAR-T therapy required an inpatient hospital stay, but the center is shifting some patients to its outpatient infusion center to receive treatment. The shift will begin in late July, according to a July 5 system news release.

At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.

Advertisement

Next Up in Oncology

Advertisement